Breaking News Instant updates and real-time market news.

SWN

Southwestern Energy

$11.89

0.54 (4.76%)

, RRC

Range Resources

$36.75

1.57 (4.46%)

09:55
12/01/16
12/01
09:55
12/01/16
09:55

Early notable gainers among liquid option names on December 1st

Notable gainers among liquid option names this morning include Southwestern Energy (SWN) $11.98 +0.64, Range Resources (RRC) $36.67 +1.50, Ford (F) $12.43 +0.47, AutoNation (AN) $46.40 +1.71, and Dover (DOV) $75.31 +2.67.

SWN

Southwestern Energy

$11.89

0.54 (4.76%)

RRC

Range Resources

$36.75

1.57 (4.46%)

F

Ford

$12.37

0.41 (3.43%)

AN

AutoNation

$45.43

0.77 (1.72%)

DOV

Dover

$75.55

2.94 (4.05%)

  • 10

    Jan

SWN Southwestern Energy
$11.89

0.54 (4.76%)

11/28/16
BMOC
11/28/16
UPGRADE
BMOC
Outperform
Southwestern Energy upgraded on valuation, potential gas upturn at BMO Capital
As noted earlier, BMO Capital upgraded Southwestern Energy to Outperform from Market Perform. Analyst Dan McSpirit upgraded the stock based on valuation and his belief that the natural gas supply/demand balance could improve. Target $18.
11/28/16
BMOC
11/28/16
UPGRADE
BMOC
Outperform
Southwestern Energy upgraded to Outperform from Market Perform at BMO Capital
10/05/16
MZHO
10/05/16
INITIATION
Target $20
MZHO
Buy
Southwestern Energy initiated with a Buy at Mizuho
Mizuho analyst Timothy Rezvan initiated Southwestern Energy with a Buy and a $20 price target.
11/10/16
KLRG
11/10/16
UPGRADE
Target $14
KLRG
Buy
Southwestern Energy upgraded to Buy from Accumulate at KLR Group
KLR Group analyst John Gerdes upgraded Southwestern Energy to Buy citing valuation with the shares down over 30% in the past month. The analyst keeps a $14 price target for the shares.
RRC Range Resources
$36.75

1.57 (4.46%)

10/31/16
GSCO
10/31/16
UPGRADE
Target $47
GSCO
Conviction Buy
Range Resources upgraded to Conviction Buy from Neutral at Goldman
Goldman analyst Brian Singer upgraded Range Resources to Conviction Buy from Neutral with a $47 price target citing favorable exposure to Henry Hub and NGLs prices, underappreciated production growth, and valuation.
09/28/16
MITR
09/28/16
INITIATION
Target $47
MITR
Buy
Range Resources coverage assumed with a Buy at GMP Securities
GMP Securities analyst Karl Chalabala assumed coverage on Range Resources with a Buy and a $47 price target.
10/07/16
JPMS
10/07/16
UPGRADE
Target $46
JPMS
Overweight
Range Resources upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Arun Jayaram upgraded Range Resources to Overweight saying the recent underperformance of the shares creates an attractive risk/reward opportunity. Range has a "structurally advantaged position" at the low-end of the cost curve in the Marcellus and Northern Louisiana with a "vast inventory of undrilled locations," Jayaram tells investors in a research note. The analyst lowered his price target for the shares to $46 from $48.
11/17/16
BMOC
11/17/16
UPGRADE
BMOC
Outperform
Range Resources upgraded to Outperform from Market Perform at BMO Capital
F Ford
$12.37

0.41 (3.43%)

11/22/16
BREN
11/22/16
INITIATION
Target $10
BREN
Sell
Ford initiated with a Sell at Berenberg
Target $10.
10/31/16
10/31/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ford (F) upgraded to Neutral from Underperform at Daiwa. 2. Chevron (CVX) upgraded to Conviction Buy from Neutral at Goldman with analyst Neil Mehta saying that after a decade of relatively flat production, the company is positioned for "strong volume improvement." 3. Fossil (FOSL) upgraded to Mixed from Negative at OTR Global with the firm saying checks indicate the response to Michael Kors (KORS) watches has been strong. 4. ADTRAN (ADTN) upgraded to Outperform from Market Perform at Northland with analyst Tim Savageaux citing the share pullback over merger concerns of its top customer CenturyLink (CTL). 5. Deere (DE) upgraded to Outperform from Neutral at Baird with analyst Mircea Dobre saying that North American large ag equipment is back to multi-decade lows and there is a sign of demand emerging outside the U.S. and there are meaningful cost savings in the pipeline. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/30/16
MACQ
11/30/16
INITIATION
Target $13
MACQ
Neutral
Ford initiated with a Neutral at Macquarie
Macquaire analyst Takuo Katayama initiated Ford with a Neutral and a $13 price target saying the company lacks catalysts over the near-term and its new product flow is underwhelming and expects it to remain that way until late 2018.
10/31/16
DAIW
10/31/16
UPGRADE
DAIW
Hold
Ford upgraded to Neutral from Underperform at Daiwa
AN AutoNation
$45.43

0.77 (1.72%)

10/31/16
10/31/16
DOWNGRADE
Target $45

Neutral
AutoNation downgraded to Neutral on increased costs at BofA/Merrill
As previously reported, BofA/Merrill downgraded AutoNation to Neutral and lowered its price target to $45 from $66. Analyst John Murphy said the company's business transformation announcement appears to be risky and will result in excessive costs, management distraction, and diverts capital from share repurchases and acquisitions.
10/31/16
10/31/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Nike (NKE) downgraded to Underperform from Neutral at BofA/Merrill with analyst Robert Ohmes citing share loss and lack of innovation. 2. AbbVie (ABBV) downgraded to Neutral from Outperform at Credit Suisse with analyst Vamil Divan saying he is increasingly concerned about Humira's longevity given the more challenging payer environment and increasing calls for further pricing transparency. 3. Home Depot (HD) and Lowe's (LOW) downgraded to Neutral from Overweight at Piper Jaffray. 4. Exxon Mobil (XOM) downgraded to Neutral from Conviction Buy at Goldman with analyst Neil Mehta citing a lack of catalysts to drive the stock higher. 5. AutoNation (AN) downgraded to Neutral from Buy at BofA/Merrill with analyst John Murphy saying the company's business transformation announcement appears to be risky and will result in excessive costs, management distraction, and diverts capital from share repurchases and acquisitions. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/31/16
BOFA
10/31/16
DOWNGRADE
BOFA
Neutral
AutoNation downgraded to Neutral from Buy at BofA/Merrill
10/06/16
10/06/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AutoNation (AN) upgraded to Neutral from Sell at Goldman with analyst David Tamberrino saying valuation has bottomed and could be flat to slightly up in the near-term as SAAR bounces around the low-to-mid 17M range. 2. Trina Solar (TSL), Yingli Green Energy (YGE), and JA Solar (JASO) were upgraded to Buy from Sell at Axiom while the firm upgraded SolarCity (SCTY) to Hold from Sell. 3. PNC Financial (PNC) upgraded to Market Perform from Underperform at Raymond James with analyst David Long saying negative earnings revisions over the past two years have likely hit an inflection point. 4. Big 5 Sporting (BGFV) upgraded to Buy from Hold at Deutsche Bank with analyst Mike Baker citing accelerating sales trends and higher earnings power from profitability improvements. 5. Booz Allen (BAH) upgraded to Outperform from Market Perform at Raymond James with analyst Brian Gesuale saying the recent selloff creates an attractive entry point. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
DOV Dover
$75.55

2.94 (4.05%)

10/07/16
SUSQ
10/07/16
INITIATION
Target $77
SUSQ
Neutral
Dover initiated with a Neutral at Susquehanna
Susquehanna analyst Robert Barry initiated Dover with a Neutral and a $77 price target.
07/26/16
BOFA
07/26/16
NO CHANGE
BOFA
Dover added ot hte US 1 List at BofA/Merrill
BofA/Merrill added Dover to the US 1 List saying Energy downside appears limited and overall earnings appear to be stabilizing.
07/13/16
BOFA
07/13/16
NO CHANGE
Target $85
BOFA
Buy
Dover price target raised to $85 from $75 at BofA/Merrill
BofA/Merrill analyst Andrew Obin raised Buy rated Dover's price target to $85 from $75 based on a higher multiple driven by higher energy estimates and strategic nationality on the Energy business.
06/10/16
06/10/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on the today's top five analyst upgrades with this list compiled by The Fly: 1. Dover (DOV) upgraded to Outperform from Market Perform at Bernstein with an $87 price target. The firm thinks that the oil-related headwinds the company had been experiencing have peaked. It says that the company's non-oil business now accounts for 93% of its earnings, up from about 60% previously, and Bernstein expects those units to generate low to mid single digit percentage organic growth. Additionally, the firm is extremely upbeat on the company's acquisition of Wayne, saying that the deal increases the value of Dover's stock by $7 per share. 2. Joy Global (JOY) upgraded to Outperform from Market Perform at FBR Capital by analyst Lucas Pipes, who also raised its price target for shares to $25 from $14. The analyst has increased confidence Joy's growth opportunities following its strategic wins in India and the Canadian oil sands and notes the company's organic order rate is tracking well against his estimates. 3. Ducommun (DCO) upgraded to Buy from Hold at Canaccord, which raised its price target to $23 from $19 on Ducommun shares. The firm cited better visibility, execution and de-leveraging of its balance sheet. The recent divestitures are expected to significantly contribute to improved margins, the firm said. 4. Pentair (PNR) upgraded to Buy from Neutral at Seaport Global by analyst Ryan Cassil, who raised his price target to $70 from $59. The analyst believes the worst margin performance is behind the company in its V&C segment and has increased confidence in management's forecast for decrementals to be reduced by half in Q2 as volumes increase seasonally and high-cost inventory is turned. 5. U.S. Concrete (USCR) upgraded to Buy from Neutral at Sidoti by analyst Michael Conti, who raised his price target to $90 from $72. The analyst views the capital raise from debt refinancing as a catalyst for acquisitions. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

, ESALY

Eisai

$57.91

0.59 (1.03%)

04:55
12/04/16
12/04
04:55
12/04/16
04:55
Conference/Events
American Epilepsy Society to hold annual meeting »

70th Annual Meeting of…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

ESALY

Eisai

$57.91

0.59 (1.03%)

GWPH

GW Pharmaceuticals

$112.32

3.04 (2.78%)

IART

Integra LifeSciences

$75.78

-1.07 (-1.39%)

MDT

Medtronic

$72.01

0.13 (0.18%)

MNK

Mallinckrodt

$53.61

0.51 (0.96%)

NVTA

Invitae

$6.95

0.16 (2.36%)

SAGE

SAGE Therapeutics

$49.02

-0.23 (-0.47%)

WTKWY

Wolters Kluwer

$34.08

-0.39 (-1.13%)

ZGNX

Zogenix

$13.05

0.35 (2.76%)

ZYNE

Zynerba

$13.64

0.83 (6.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 14

    Dec

  • 28

    Jan

  • 27

    Apr

CELG

Celgene

$117.63

-1.24 (-1.04%)

04:55
12/04/16
12/04
04:55
12/04/16
04:55
Conference/Events
Celgene to hold an analyst and investor event »

Management holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

INCY

Incyte

$102.02

2.09 (2.09%)

, PFE

Pfizer

$31.63

0.17 (0.54%)

04:55
12/04/16
12/04
04:55
12/04/16
04:55
Conference/Events
Canaccord biotech analyst to hold a dinner meeting »

In conjunction with the…

INCY

Incyte

$102.02

2.09 (2.09%)

PFE

Pfizer

$31.63

0.17 (0.54%)

LLY

Eli Lilly

$67.71

1.74 (2.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

  • 15

    Dec

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

, KITE

Kite Pharma

$50.76

0.04 (0.08%)

21:25
12/03/16
12/03
21:25
12/03/16
21:25
Conference/Events
Canaccord biotech analyst to hold a dinner meeting »

In conjunction with the…

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

KITE

Kite Pharma

$50.76

0.04 (0.08%)

BLUE

bluebird bio

$69.75

1.1 (1.60%)

NVS

Novartis

$68.17

0.42 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 03

    Dec

  • 06

    Dec

09:15
12/03/16
12/03
09:15
12/03/16
09:15
General news
Breaking General news story  »

New York Federal Reserve…

09:15
12/03/16
12/03
09:15
12/03/16
09:15
General news
Breaking General news story  »

New York Federal Reserve…

04:55
12/03/16
12/03
04:55
12/03/16
04:55
General news
Breaking General news story  »

New York Federal Reserve…

04:55
12/03/16
12/03
04:55
12/03/16
04:55
General news
Breaking General news story  »

New York Federal Reserve…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

, ESALY

Eisai

$57.91

0.59 (1.03%)

04:55
12/03/16
12/03
04:55
12/03/16
04:55
Conference/Events
American Epilepsy Society to hold annual meeting »

70th Annual Meeting of…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

ESALY

Eisai

$57.91

0.59 (1.03%)

GWPH

GW Pharmaceuticals

$112.32

3.04 (2.78%)

IART

Integra LifeSciences

$75.78

-1.07 (-1.39%)

MDT

Medtronic

$72.01

0.13 (0.18%)

MNK

Mallinckrodt

$53.61

0.51 (0.96%)

NVTA

Invitae

$6.95

0.16 (2.36%)

SAGE

SAGE Therapeutics

$49.02

-0.23 (-0.47%)

WTKWY

Wolters Kluwer

$34.08

-0.39 (-1.13%)

ZGNX

Zogenix

$13.05

0.35 (2.76%)

ZYNE

Zynerba

$13.64

0.83 (6.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 14

    Dec

  • 28

    Jan

  • 27

    Apr

WMT

Wal-Mart

$70.88

0.21 (0.30%)

18:17
12/02/16
12/02
18:17
12/02/16
18:17
Periodicals
Wal-Mart to pay $7.5M to settle same-sex spouse benefit case, Reuters reports »

Wal-Mart said it would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

18:14
12/02/16
12/02
18:14
12/02/16
18:14
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

, ALIOF

Actelion

$206.01

15.21 (7.97%)

18:11
12/02/16
12/02
18:11
12/02/16
18:11
Periodicals
Johnson & Johnson said to raise offer for Actelion above $250, Bloomberg says »

Johnson &…

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

ALIOF

Actelion

$206.01

15.21 (7.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$79.10

0.3 (0.38%)

18:00
12/02/16
12/02
18:00
12/02/16
18:00
Hot Stocks
Celanese to raise list, off-list selling prices for paraformaldehyde »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, GMED

Globus Medical

$21.89

0.12 (0.55%)

17:56
12/02/16
12/02
17:56
12/02/16
17:56
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: HomeStreet…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

GMED

Globus Medical

$21.89

0.12 (0.55%)

BGS

B&G Foods

$42.50

0.2 (0.47%)

ZEN

Zendesk

$21.17

0.34 (1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 09

    Jan

ZEN

Zendesk

$21.17

0.34 (1.63%)

17:53
12/02/16
12/02
17:53
12/02/16
17:53
Hot Stocks
Zendesk says SVPs Amanda Kleha and Marcus Bragg to resign »

On November 29, Amanda…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

AIXG

Aixtron

$3.97

-0.05 (-1.24%)

17:42
12/02/16
12/02
17:42
12/02/16
17:42
Periodicals
President Obama blocks China's Fujian from acquiring Aixtron, CNBC reports »

President Barack Obama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

CEMEX

$7.83

0.09 (1.16%)

17:31
12/02/16
12/02
17:31
12/02/16
17:31
Hot Stocks
CEMEX to divest ready-mix concrete pumping assets in Mexico »

CEMEX announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRNE

Sorrento Therapeutics

$5.15

-0.1 (-1.90%)

17:30
12/02/16
12/02
17:30
12/02/16
17:30
Syndicate
Breaking Syndicate news story on Sorrento Therapeutics »

Sorrento files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

MBRX

Moleculin Biotech

$2.63

-0.14 (-5.05%)

17:29
12/02/16
12/02
17:29
12/02/16
17:29
Syndicate
Breaking Syndicate news story on Moleculin Biotech »

Moleculin Biotech files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

NEOG

Neogen

$61.59

-1.46 (-2.32%)

17:28
12/02/16
12/02
17:28
12/02/16
17:28
Hot Stocks
Neogen acquires U.K.-based Quat-Chem, terms undisclosed »

Neogen announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RRC

Range Resources

$36.36

-0.23 (-0.63%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Hot Stocks
Breaking Hot Stocks news story on Range Resources »

SailingStone Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$103.74

-1.01 (-0.96%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Syndicate
Breaking Syndicate news story on EOG Resources »

EOG Resources files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

17:22
12/02/16
12/02
17:22
12/02/16
17:22
Hot Stocks
Breaking Hot Stocks news story on HomeStreet, UMB Financial »

HomeStreet to replace UMB…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

, IM

Ingram Micro

$38.88

1.31 (3.49%)

17:21
12/02/16
12/02
17:21
12/02/16
17:21
Hot Stocks
UMB Financial to replace Ingram Micro in S&P 400 as of 12/6 close »

Tianjin Tianhai…

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

17:20
12/02/16
12/02
17:20
12/02/16
17:20
Hot Stocks
Globus Medical to replace Talen Energy in S&P 400 as of 12/6 close »

Riverstone Holdings is…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.